This is a more complete and concise version descri
Post# of 157779

It also discusses the fact that CytoDyn track Leronlimab's effectiveness by measuring PDL1, CTCs and CAMLs and that this information, together with the resultant Comparison in Diagnostic Imaging, CT and MRI which measure the reduction in Tumor size, as a combined body of evidence, as the Early, Interim data presented to get the S3 executed.
AI Generated Detailed Summary on CTC and CAML Dynamics with Leronlimab Treatment

